Literature DB >> 29674423

Now Is the Time to Use 18F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!

David Groheux1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29674423     DOI: 10.2967/jnumed.118.210922

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  1 in total

1.  Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

Authors:  Sylvie Giacchetti; Lilith Faucheux; Charlotte Gardair; Caroline Cuvier; Anne de Roquancourt; Luca Campedel; David Groheux; Cedric de Bazelaire; Jacqueline Lehmann-Che; Catherine Miquel; Laurence Cahen Doidy; Malika Amellou; Isabelle Madelaine; Fabien Reyal; Laetitia Someil; Hamid Hocini; Christophe Hennequin; Luis Teixeira; Marc Espié; Sylvie Chevret; Vassili Soumelis; Anne-Sophie Hamy
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.